U.S. Markets closed

Biotech Giant Tumbles On Downgrade Amid Payer Pushback In Europe

ALLISON GATLIN
Biotech Giant Tumbles On Downgrade Amid Payer Pushback In Europe

Vertex Pharmaceuticals stock slipped below its 50-day moving average Tuesday after sustaining a downgrade and price target cut on European opposition to its cystic fibrosis treatments.